Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Participants maintaining the highest 12 mg dose of retatrutide lost an average of 30.3% of their body weight (38.5 kg) at 104 weeks, while those moving from the lowest 4 mg dose to the maximum tolerated dose lost an average of 27.9% of their body weight (33.2 kg)
Step 4: If you have obesity plus another condition, lead with the comorbidity
When to Continue Your GLP-1 Medication For mild to moderate colds and flu, most people can safely continue their regular GLP-1 medication schedule
Mounjaro Treatment, an FDA-approved injectable for type 2 diabetes and weight management, enhances insulin sensitivity and appetite control
Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity
US$ 20.91
US$ 27.21
US$ 21.15
US$ 24.62
US$ 28.21
US$ 22.96
US$ 20.69
US$ 22.66
US$ 23.93
US$ 24.35
US$ 21.55
